Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Ok, so you’re going to take the cash

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
bwolfy2002 Member Profile
 
Followed By 5
Posts 1,084
Boards Moderated 0
Alias Born 03/07/18
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/15/2020 5:06:59 PM
Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) Edgar (US Regulatory) - 9/14/2020 4:31:44 PM
SA Breaking News: ALYI - Alternet Systems revenue surging with new potential customers InvestorsHub NewsWire - 9/14/2020 10:10:04 AM
Traders News Source Identifies Tomorrows NASDAQ's InvestorsHub NewsWire - 9/3/2020 8:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/1/2020 5:34:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/1/2020 2:57:56 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 9/1/2020 1:47:41 PM
MICROCAP DAILY - The Exciting Story of Puration Inc (OTCMKTS: PURA) InvestorsHub NewsWire - 8/26/2020 9:02:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:31:34 PM
Annual Report (10-k) Edgar (US Regulatory) - 8/14/2020 5:19:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/31/2020 5:21:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 4:34:37 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 5:07:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 4:31:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/19/2020 5:19:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2020 7:24:49 PM
Proxy Soliciting Materials (revised) (prer14a) Edgar (US Regulatory) - 6/8/2020 5:28:53 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/8/2020 6:02:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/2/2020 5:01:56 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/2/2020 8:01:17 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 5/15/2020 8:47:08 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/12/2020 6:00:59 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 4/30/2020 5:28:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2020 5:29:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2020 5:03:47 PM
bwolfy2002   Monday, 05/25/20 10:53:53 AM
Re: hopester post# 80054
Post # of 119164 
Ok, so you’re going to take the cash cycle and call it debt, that’s fine. So to be clear it’s not debt used for financing. Ok, so with that they have what about $41MM in “debt”.

How many vials sold will cover that? What’s that as a part of their market cap? How many new shares would it take to cover that at today’s price? How much dilution would that be?

Until it is no longer a clinical biotech, there will not be sales everyone knows this. One would buy in for the potential for sales. You may sell short hoping it loses, sure, but don’t act like a pre-revenue biotech is failing by not having sales or by having costs to bring the product to market it will one day sell... that’s silly.

Let’s leave be for now the fact that this company can save lives. That rooting for it is rooting for humanity. Should make casting shadows seem less enjoyable I would think. I’m often wrong about human nature, but as far as the company and my investment in it, everything is has been A ok.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences